Bionano Genomics, Inc. (BNGO) Operating cash flow 2017–2025
Bionano Genomics, Inc. (BNGO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$16.3MFY2025 · since FY2017: -$20.8M → -$16.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.3M | +76.3% |
| FY2024 | -$68.9M | +44.9% |
| FY2023 | -$125.2M | -0.3% |
| FY2022 | -$124.8M | -73.5% |
| FY2021 | -$71.9M | -87.7% |
| FY2020 | -$38.3M | -29.7% |
| FY2019 | -$29.5M | -48.1% |
| FY2018 | -$19.9M | +4.2% |
| FY2017 | -$20.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice